NR1H4 and breast cancer: Thus, our first aim was to investigate the role of activated FXR on leptin-induced cell proliferation and motility using as experimental models poorly invasive/low metastasizing MCF-7 estrogen receptor (ER) α positive and highly invasive and metastatic MDA-MB-231 (ERα-negative) human breast cancer cells.